These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9663706)

  • 1. Cleavage of rhamnose from ristocetin A removes its ability to induce platelet aggregation.
    Bardsley B; Williams DH; Baglin TP
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):241-4. PubMed ID: 9663706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets.
    Scott JP; Montgomery RR; Retzinger GS
    J Biol Chem; 1991 May; 266(13):8149-55. PubMed ID: 2022635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.
    Carew JA; Quinn SM; Stoddart JH; Lynch DC
    J Clin Invest; 1992 Dec; 90(6):2258-67. PubMed ID: 1469086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
    Gjønnaess E; Solum NO; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
    Moore A; Ross GD; Nachman RL
    J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib in patients with steroid-responsive nephrotic syndrome.
    Taira K; Kamitsuji H; Okajima C; Fujimura Y
    Haemostasis; 1990; 20(4):219-28. PubMed ID: 2242824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inhibition by trinitrophenylation of the ristocetin cofactor activity of von Willebrand factor.
    Santoro SA; Cowan JF
    Biochim Biophys Acta; 1984 Feb; 797(2):178-85. PubMed ID: 6607747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies.
    Frontroth JP; Favaloro EJ
    Methods Mol Biol; 2017; 1646():473-494. PubMed ID: 28804849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ristocetin induced platelet aggregation in children with nephrotic syndrome].
    Taira K; Okajima C; Yamashita T; Kawahara S; Matsunaga T; Nakajima M; Kamitsuji H
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):659-66. PubMed ID: 2214316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated recombinant domain of von Willebrand factor displaying increased sensitivity to ristocetin.
    Hayashi T; Ware J; Niiya K; Sakuragawa N
    Am J Hematol; 1996 Aug; 52(4):248-53. PubMed ID: 8701941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vancomycin on ristocetin and bovine PAF-induced agglutination of human platelets.
    Baugh RF; Jacoby C; Brown JE; Hougie C
    Thromb Res; 1978 Mar; 12(3):511-21. PubMed ID: 306689
    [No Abstract]   [Full Text] [Related]  

  • 15. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
    Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
    Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ristocetin and von Willebrand factor analysis.
    Light J; Williams CE; Entwistle MB
    Med Lab Sci; 1987 Jul; 44(3):272-9. PubMed ID: 3501515
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma components which interfere with ristocetin-induced platelet aggregation.
    Baugh RF; Brown JE; Hougie C
    Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets.
    Kupinski JM; Miller JL
    Thromb Res; 1986 Aug; 43(3):335-44. PubMed ID: 3016944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of wheat germ agglutinin aggregation of platelets by von Willebrand protein and by a 116,000 molecular weight tryptic fragment.
    Martin SE; Francis CW; Marder VJ
    Thromb Res; 1983 Aug; 31(3):437-49. PubMed ID: 20218000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of ristocetin on platelets.
    Koutts J; Stott L; Firkin BG
    Am J Hematol; 1976; 1(3):313-7. PubMed ID: 1087117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.